Study finds weight-loss drugs like Ozempic may lower dementia risk but raise other health concerns

A new study suggests that weight-loss drugs like Ozempic may help reduce the risk of dementia and other health issues. This research, involving 200,000 U.S. patients, indicates potential benefits beyond weight loss, including lower risks for heart disease and addiction disorders. However, the study also highlights increased risks associated with these medications, such as nausea, vomiting, and pancreatitis. Experts caution against using these drugs for conditions other than diabetes and obesity until further research confirms their safety and effectiveness. The findings show that GLP-1 medications affect both the stomach and brain, influencing appetite control. Future studies are needed to explore these effects in more diverse populations, as the current data primarily comes from older, white men.